Nabriva Therapeutics Hires Peter Wolf as General Counsel and Corporate Secretary
October 15, 2015 07:16 ET
|
Nabriva Therapeutics AG
Vienna, Austria and King of Prussia, Pa., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of...
Nabriva Therapeutics Hires Will Sargent as Vice President of Commercial Strategy and Investor Relations
October 14, 2015 07:06 ET
|
Nabriva Therapeutics AG
VIENNA, Austria and KING OF PRUSSIA, Pa., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of...
Nabriva Presents Data on Lefamulin at the 2015 ID Week in San Diego
October 13, 2015 07:06 ET
|
Nabriva Therapeutics AG
VIENNA, Austria and KING OF PRUSSIA, Pa., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of...
Nabriva Therapeutics Announces Exercise of Over-Allotment Option
September 30, 2015 16:09 ET
|
Nabriva Therapeutics AG
VIENNA, Austria and KING OF PRUSSIA, Pa., Sept. 30, 2015 (GLOBE NEWSWIRE) -- (NASDAQ:NBRV) - Nabriva Therapeutics AG announced today that the underwriters of its initial public offering have exercised...
Nabriva Therapeutics Announces Closing of Its Initial Public Offering
September 23, 2015 16:11 ET
|
Nabriva Therapeutics AG
VIENNA, Austria and KING OF PRUSSIA, Pa., Sept. 23, 2015 (GLOBE NEWSWIRE) -- (NASDAQ: NBRV) - Nabriva Therapeutics AG announced today the closing of its initial public offering of 9,000,000 American...
Nabriva Therapeutics Prices Initial Public Offering
September 17, 2015 22:19 ET
|
Nabriva Therapeutics AG
VIENNA, Austria and KING OF PRUSSIA, Pa., Sept. 17, 2015 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG announced today the pricing of its initial public offering of 9,000,000 American Depositary Shares...